The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Wormaway Plus XL Tablets For Dogs

175,504,525 mg/tablet Tablet

Chanelle Pharmaceuticals Manufacturing LimitedVPA10987/089/002

Main Information

Trade NameWormaway Plus XL Tablets For Dogs
Active SubstancesPraziquantel
Pyrantel embonate
Strength175,504,525 mg/tablet
Dosage FormTablet
Licence HolderChanelle Pharmaceuticals Manufacturing Limited
Licence NumberVPA10987/089/002

Group Information

ATC CodeQP52AA01 praziquantel
QP52AC05 febantel
QP52AF02 pyrantel
Therapeutic ClassEndoparasiticide


Licence Issued12/04/2013
Legal StatusCAM: Companion Animal Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
« Back